Novartis Launches First US 'Biosimilar' Drug

被引：0

|

作者：

不详

机构：

来源：

JOURNAL OF DRUGS IN DERMATOLOGY | 2015年 / 14卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

收藏

页码：1176 / 1176

页数：1

相关论文

共 50 条

[31] US NHGRI launches chemical attack on drug development gap
Garber, K
[J]. NATURE BIOTECHNOLOGY, 2003, 21 (11) : 1253 - 1254
[32] US NHGRI launches chemical attack on drug development gap
Ken Garber
[J]. Nature Biotechnology, 2003, 21 : 1253 - 1254
[33] Fractured European market undermines biosimilar launches
Moran, Nuala
[J]. NATURE BIOTECHNOLOGY, 2008, 26 (01) : 5 - 6
[34] Fractured European market undermines biosimilar launches
Nuala Moran
[J]. Nature Biotechnology, 2008, 26 : 5 - 6
[35] Novartis bets US$2.9 billion on MorphoSys and an anti-myelofibrosis drug
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2024, 23 : 162 - 162
[36] Novartis bets US$2.9 billion on MorphoSys and an anti-myelofibrosis drug
Mullard, Asher
[J]. NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (03) : 162 - 162
[37] Novartis launches website customized for renal transplant recipients and professionals
不详
[J]. DIALYSIS & TRANSPLANTATION, 2001, 30 (05) : 276 - 276
[38] Novartis bases research in US
Reisch, M
[J]. CHEMICAL & ENGINEERING NEWS, 2002, 80 (19) : 5 - 5
[39] US approves Novartis merger
不详
[J]. CHEMISTRY IN BRITAIN, 1997, 33 (02) : 8 - 8
[40] Novartis latest to move to US
不详
[J]. CHEMISTRY & INDUSTRY, 2002, (10) : 10 - 10

← 1 2 3 4 5 →